CS logo
small CS logo
Regions Hospital

Saint Paul, Minnesota, United States
Hospital in Saint Paul, Minnesota
640 Jackson St, St Paul, MN 55101
509 (all private) Beds

About Regions Hospital


Regions Hospital is a teaching hospital located in Saint Paul, Minnesota, United States. It is now part of HealthPartners. The hospital is an ACS verified Level I Trauma Center for both children and adults, and was Minnesota's first pediatric level one trauma center.
There are 509 (all private) beds in Regions Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
179
Alliance for Clinical Trials in Oncology
45
SWOG Cancer Research Network
43
NRG Oncology
26
ECOG-ACRIN Cancer Research Group
24
HealthPartners Institute
18
Gynecologic Oncology Group
10
Wake Forest University Health Sciences
10
GOG Foundation
6
CalciMedica, Inc.
4
Otsuka Pharmaceutical Development & Commercialization, Inc.
4
Total Rows: 59

Clinical Trials at Regions Hospital


During the past decade, Regions Hospital conducted 239 clinical trials. In the 10-year time frame, 239 clinical trials started and 173 clinical trials were completed, i.e. on average, 72.4% percent of trials that started reached the finish line to date. In the past 5 years, 70 clinical trials started and 82 clinical trials were completed. i.e. 117.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22222222434335354747373728285517171818151515152626151532322020Started TrialsCompleted Trails201520162017201820192020202120220204060
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Evaluation of Galantamine in the Treatment of Alzheimer's Disease
Completed
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Completed
240
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
Completed
300
Safety and Effectiveness of Tenofovir Disoproxil Fumarate (Tenofovir DF) Plus Other Anti-HIV Drugs in HIV-Infected Patients
Completed
600
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
2000-03-01
2000-09-01
Completed
250
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
Completed
525
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2000-12-01
2014-11-01
Terminated
748

Rows per page:

1–100 of 442

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Regions Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 179 trials, followed by "Alliance for Clinical Trials in Oncology" with 45 trials sponsored, "SWOG Cancer Research Network" with 43 trials sponsored, "NRG Oncology" with 26 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored. Other sponsors include 120 different institutions and companies that sponsored additional 59 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Regions Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 177 trials as a collaborator, "NRG Oncology" with 39 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 128 different institutions and companies that were collaborators in the rest 83 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 179National CancerInstitute (NCI): 179Alliance for ClinicalTrials in Oncology: 45Alliance for ClinicalTrials in Oncology: 45SWOG Cancer ResearchNetwork: 43SWOG Cancer ResearchNetwork: 43NRG Oncology: 26NRG Oncology: 26ECOG-ACRIN CancerResearch Group: 24ECOG-ACRIN CancerResearch Group: 24HealthPartners Institute: 18HealthPartners Institute: 18Gynecologic OncologyGroup: 10Gynecologic OncologyGroup: 10Wake Forest UniversityHealth Sciences: 10Wake Forest UniversityHealth Sciences: 10GOG Foundation: 6GOG Foundation: 6CalciMedica, Inc.: 4CalciMedica, Inc.: 4

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 177National CancerInstitute (NCI): 177NRG Oncology: 39NRG Oncology: 39Canadian Cancer TrialsGroup: 11Canadian Cancer TrialsGroup: 11NCIC Clinical Trials Group: 9NCIC Clinical Trials Group: 9SWOG Cancer ResearchNetwork: 8SWOG Cancer ResearchNetwork: 8Cancer and LeukemiaGroup B: 7Cancer and LeukemiaGroup B: 7Medical University ofSouth Carolina: 7Medical University ofSouth Carolina: 7National Institute ofNeurological Disordersand Stroke (NINDS): 7National Institute ofNeurological Disordersand Stroke (NINDS): 7Eastern CooperativeOncology Group: 6Eastern CooperativeOncology Group: 6North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5

Clinical Trials Conditions at Regions Hospital


According to Clinical.Site data, the most researched conditions in "Regions Hospital" are "Recurrent Ovarian Carcinoma" (14 trials), "Ovarian Seromucinous Carcinoma" (11 trials), "Recurrent Breast Carcinoma" (11 trials), "Invasive Breast Carcinoma" (10 trials) and "Recurrent Fallopian Tube Carcinoma" (10 trials). Many other conditions were trialed in "Regions Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Regions Hospital


Most popular intervention types in "Regions Hospital" are "Drug" (329 trials), "Other" (236 trials), "Biological" (134 trials), "Procedure" (95 trials) and "Radiation" (68 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (114 trials), "Quality-of-Life Assessment" (100 trials), "Questionnaire Administration" (59 trials), "Paclitaxel" (45 trials) and "Carboplatin" (40 trials). Other intervention names were less common.

Clinical Trials Genders at Regions Hospital


The vast majority of trials in "Regions Hospital" are 358 trials for "All" genders, 64 trials for "Female" genders and 20 trials for "Male" genders.

Clinical Trials Status at Regions Hospital


Currently, there are NaN active trials in "Regions Hospital". undefined are not yet recruiting, 100 are recruiting, 154 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 139 completed trials in Regions Hospital, 10 suspended trials, and 30 terminated clinical trials to date.
Out of the total trials that were conducted in Regions Hospital, 15 "Phase 1" clinical trials were conducted, 192 "Phase 2" clinical trials and 203 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 30 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 203Phase 3: 203Phase 2: 192Phase 2: 192Not Applicable: 30Not Applicable: 30Phase 1: 15Phase 1: 15Phase 4: 8Phase 4: 8Early Phase 1: 3Early Phase 1: 3

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 154Active, not recruiting: 154Completed: 139Completed: 139Recruiting: 100Recruiting: 100Terminated: 30Terminated: 30Suspended: 10Suspended: 10Unknown status: 7Unknown status: 7Enrolling by invitation: 1Enrolling by invitation: 1Withdrawn: 1Withdrawn: 1

Departments of Regions Hospital


Regions Hospital has several departments that took part in Clinical trials: "Regions Hospital Cancer Care Center" - 146 trials, "Health Partners Dental Group" - 13 trials, "TRIA Orthopaedic Center" - 3 trials, "Park Nicollet Heart Center" - 2 trials, "Park Nicollet International Diabetes Center" - 2 trials
Departments List
Total Rows: 5